Emergent BioSolutions to Report Third Quarter 2026 Financial Results on November 2, 2026
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 6.23 +0.03 (0.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.20 | 52 Week High | $44.38 | |||
| Open | $6.20 | 52 Week Low | $24.47 | |||
| Day High | $6.36 | P/E | 311.50 | |||
| Day Low | $6.09 | EPS | $0.02 | |||
| Volume | 838,388 | |||||
